Evidence map›Paper›PMID 22674805›Full record

ArticleBlood2012

Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability.

Luke H Hoeppner, Kathryn N Phoenix, Karl J Clark, Resham Bhattacharya, Xun Gong, Tracey E Sciuto, Pawan Vohra, Sandip Suresh, Santanu Bhattacharya, Ann M Dvorak and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. PLCβ2 Promotes VEGF-Induced Vascular Permeability.Arteriosclerosis, thrombosis, and vascular biology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Identifying and treating ROBO1The Prostate · 2020
    Article
  15. Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  16. Endothelial CaInternational journal of molecular sciences · 2019
    Review
  17. Article
  18. Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.International journal of molecular sciences · 2018
    Review
  19. Article
  20. IPCellular and molecular life sciences : CMLS · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Luke H HoeppnerDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Kathryn N Phoenix
Karl J Clark
Resham Bhattacharya
Xun Gong
Tracey E Sciuto
Pawan Vohra
Sandip Suresh
Santanu Bhattacharya
Ann M Dvorak
Stephen C Ekker
Harold F Dvorak
Kevin P Claffey
Debabrata Mukhopadhyay
Mayo Clinic · USUConn Health · USBeth Israel Deaconess Medical Center · USCenter for Vascular Biology Research · USHarvard University · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to BedsideR01CA150190 · NCI · MAYO CLINIC ROCHESTER · PI MIERKE, DALE F, MUKHOPADHYAY, DEBABRATA · 2010 to 2021
$5.7M
Distinct Pathways of VPF/VEGF ReceptorsR01HL070567 · NHLBI · MAYO CLINIC ROCHESTER · PI MUKHOPADHYAY, DEBABRATA · 2002 to 2014
$4.7M
Regulatory Pathways and Role of VPF/VEGF in Renal CancerR01CA078383 · NCI · MAYO CLINIC ROCHESTER · PI MUKHOPADHYAY, DEBABRATA · 2004 to 2019
$4.5M
Tumor Microenvironment/Angiogenesis Training GrantT32CA148073 · NCI · MAYO CLINIC ROCHESTER · PI MC NIVEN, MARK A. · 2010 to 2014
$1.2M
REGULATORY PATHWAYS AND ROLE OF VPF/VEGF IN RENAL CANCERR29CA078383 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MUKHOPADHYAY, DEBABRATA · 1998 to 2002
$383k
NCI NIH HHS CA150190NCI NIH HHS CA78383NCI NIH HHS R01 CA078383NCI NIH HHS R01 CA150190NCI NIH HHS R29 CA078383NCI NIH HHS T32 CA148073NHLBI NIH HHS HL70567NHLBI NIH HHS R01 HL070567NIDDK NIH HHS P30 DK084567
6 · The paper itself

Abstract

VEGF induces vascular permeability (VP) in ischemic diseases and cancer, leading to many pathophysiological consequences. The molecular mechanisms by which VEGF acts to induce hyperpermeability are poorly understood and in vivo models that easily facilitate real-time, genetic studies of VP do not exist. In the present study, we report a heat-inducible VEGF transgenic zebrafish (Danio rerio) model through which VP can be monitored in real time. Using this approach with morpholino-mediated gene knock-down and knockout mice, we describe a novel role of phospholipase Cβ3 as a negative regulator of VEGF-mediated VP by regulating intracellular Ca2+ release. Our results suggest an important effect of PLCβ3 on VP and provide a new model with which to identify genetic regulators of VP crucial to several disease processes.

Indexed as

Capillary PermeabilityAnimalsAnimals, Genetically ModifiedCalcium SignalingCells, CulturedEmbryo, NonmammalianEndothelium, VascularHeat-Shock ResponseHigh-Throughput Screening AssaysHSP70 Heat-Shock ProteinsHumansHuman Umbilical Vein Endothelial CellsMiceMice, KnockoutMorpholinosPhospholipase C betaHSP70 Heat-Shock ProteinsMorpholinosPhospholipase C betaPlcb3 protein, mouseRecombinant ProteinsVascular Endothelial Growth Factor AVEGFA protein, humanZebrafish Proteins

Identifiers

PMID22674805
PMCPMC3447777
OpenAlexW2064889370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.